Yue Yang, Li Hua Gong, Fu Hua Peng, Tao Jiang, Jian Guo Hu, Hong Dong Liu, Bin Li, Yin Xia Yang, Jing Ying Peng, Xue Mei Gao
{"title":"Two new compounds from Pentadesma butyracea and their biological activities","authors":"Yue Yang, Li Hua Gong, Fu Hua Peng, Tao Jiang, Jian Guo Hu, Hong Dong Liu, Bin Li, Yin Xia Yang, Jing Ying Peng, Xue Mei Gao","doi":"10.1016/j.phytol.2025.02.012","DOIUrl":null,"url":null,"abstract":"<div><div>Two new compounds (<strong>1</strong>-<strong>2</strong>) and twenty-two known compounds (<strong>3</strong>-<strong>24</strong>) were isolated from the ethanol extract of the stems and leaves of <em>Pentadesma butyracea</em> Sabine (Clusiaceae). The structures of compounds <strong>1</strong>-<strong>2</strong> were elucidated by spectroscopic methods, including extensive 1D- and 2D-NMR spectroscopy and HRMS techniques. According to previous literature research and molecular docking, we tested antiproliferative and <em>α</em>-glucosidase inhibitory activities of these compounds. Compounds <strong>1</strong>, <strong>5</strong>, and <strong>6</strong> showed good <em>α</em>-glucosidase inhibitory activities with IC<sub>50</sub> values of 23.12, 3.60, and 16.83 <em>μ</em>M, respectively. Molecular docking results showed that compounds <strong>1</strong>, <strong>5</strong>, and <strong>6</strong> have strong binding affinities with <em>α</em>-glucosidase. In addition, the antiproliferative activities of compounds <strong>1</strong>, <strong>5</strong>, and <strong>6</strong> against human cancer A549 cells exhibited IC<sub>50</sub> values of 41.47, 19.46 and 45.75 <em>μ</em>M, respectively. Except for compound <strong>14</strong>, all the compounds were isolated from the genus <em>Pentadesma</em> for the first time. The findings propose that xanthones with isoprenyl groups may be effective lead compounds for the development of <em>α</em>-glucosidase inhibitors and anticancer therapies.</div></div>","PeriodicalId":20408,"journal":{"name":"Phytochemistry Letters","volume":"66 ","pages":"Pages 119-125"},"PeriodicalIF":1.3000,"publicationDate":"2025-03-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Phytochemistry Letters","FirstCategoryId":"99","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1874390025010249","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0
Abstract
Two new compounds (1-2) and twenty-two known compounds (3-24) were isolated from the ethanol extract of the stems and leaves of Pentadesma butyracea Sabine (Clusiaceae). The structures of compounds 1-2 were elucidated by spectroscopic methods, including extensive 1D- and 2D-NMR spectroscopy and HRMS techniques. According to previous literature research and molecular docking, we tested antiproliferative and α-glucosidase inhibitory activities of these compounds. Compounds 1, 5, and 6 showed good α-glucosidase inhibitory activities with IC50 values of 23.12, 3.60, and 16.83 μM, respectively. Molecular docking results showed that compounds 1, 5, and 6 have strong binding affinities with α-glucosidase. In addition, the antiproliferative activities of compounds 1, 5, and 6 against human cancer A549 cells exhibited IC50 values of 41.47, 19.46 and 45.75 μM, respectively. Except for compound 14, all the compounds were isolated from the genus Pentadesma for the first time. The findings propose that xanthones with isoprenyl groups may be effective lead compounds for the development of α-glucosidase inhibitors and anticancer therapies.
期刊介绍:
Phytochemistry Letters invites rapid communications on all aspects of natural product research including:
• Structural elucidation of natural products
• Analytical evaluation of herbal medicines
• Clinical efficacy, safety and pharmacovigilance of herbal medicines
• Natural product biosynthesis
• Natural product synthesis and chemical modification
• Natural product metabolism
• Chemical ecology
• Biotechnology
• Bioassay-guided isolation
• Pharmacognosy
• Pharmacology of natural products
• Metabolomics
• Ethnobotany and traditional usage
• Genetics of natural products
Manuscripts that detail the isolation of just one new compound are not substantial enough to be sent out of review and are out of scope. Furthermore, where pharmacology has been performed on one new compound to increase the amount of novel data, the pharmacology must be substantial and/or related to the medicinal use of the producing organism.